Patent ID: 7682625

Claim:
A method of treating an individual exhibiting hypoalbuminemia with a high protein concentration nutritional supplement and without excess fluids, comprising orally administering to the mammal an effective amount of a concentrated protein composition comprising about 5 to about 75 parts by weight of enzymatically hydrolyzed gelatin, about 0.02 to about 2.0 parts by weight of tryptophan, about 0.1 to about 2 parts by weight of a sweetener, and about 5 to about 100 parts by weight of an ingestible carrier, the composition comprising the essential amino acids required by the mammal, and wherein the total fluid amount administered is about 15 mL to about 60 mL, such that the individual is treated for hypoalbuminemia and the treatment does not unduly burden the mammal with excess fluids; wherein said composition comprises the following amino acids, in grams per hundred grams of protein, each value understood to include a range of ±30% by weight: Amino Acid g/100 g Protein L-Alanine 8.60 L-Arginine 7.90 L-Aspartic Acid 5.90 L-Cystine 0.07 L-Glutamic Acid 9.90 Glycine 23.10 L-Histidine 0.73 Hydroxylysine 1.00 L-Hydroxyproline 6.60 L-Isoleucine 1.30 L-Leucine 3.00 L-Lysine 4.30 L-Methionine 0.73 L-Phenylalanine 2.30 L-Proline 15.20 L-Serine 6.60 L-Threonine 2.00 L-Tryptophan 0.40 L-Tyrosine 0.70 L-Valine 2.40.